Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL31047096 | 0.84 | SMN1; SMN2 (0.42) | RAB9AMMP1MMP3MMP8SMN1; SMN2 | |
| SCHEMBL5812262 | 0.83 | ALDH1A1 (0.34) | MMP1MMP3SMN1; SMN2MEN1KMT2A | |
| SCHEMBL78979 | 0.78 | — | — | |
| SCHEMBL1387342 | 0.77 | CA12 (0.47) | RAB9AMMP1MMP3MMP8SMN1; SMN2 | |
| Oxalic Acid SCHEMBL31346826 | 0.76 | SMN1; SMN2 (0.48) | MMP1MMP3MMP8SMN1; SMN2CA12 | |
| SCHEMBL27988207 | 0.75 | CA12 (0.52) | MMP1MMP3MMP8SMN1; SMN2CA12 | |
| Hydrochloric Acid SCHEMBL1669235 | 0.75 | CA12 (0.52) | MMP1MMP3MMP8SMN1; SMN2CA12 | |
| Formic Acid SCHEMBL30516049 | 0.74 | SMN1; SMN2 (0.46) | MMP1MMP3MMP8SMN1; SMN2CA12 | |
| Fumaric Acid SCHEMBL27322852 | 0.72 | LMNA (0.46) | RAB9AMMP1MMP3MMP8SMN1; SMN2 | |
| Glycine SCHEMBL8830885 | 0.71 | KDM4E (0.45) | MMP1MMP3MMP8SMN1; SMN2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7262296-B2 | Substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-08-28 | — | — | US | disclosed |
| US-20060094874-A1 | Novel substituted aryl alkenoic acid heterocyclic amides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094874-A1 | Novel substituted aryl alkenoic acid heterocyclic amides | FABP1, LIPC, FABP2 | RAB9A 2435/4885MMP1 3456/4885MMP3 3516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.